We are live on ! Find out more
PA

Perceptive Advisors Portfolio holdings

AUM $6.66B
1-Year Est. Return 360.84%
This Fund
S&P 500
This Quarter Est. Return
+2.07%
1 Year Est. Return
+360.84%
3 Year Est. Return
+1,707.27%
5 Year Est. Return
+3,210.42%
10 Year Est. Return
+53,055.89%
AUM
$833M
AUM Growth
-$400M
Cap. Flow
-$240M
Cap. Flow %
-28.81%
Top 10 Hldgs %
56.65%
Holding
156
New
48
Increased
29
Reduced
27
Closed
47

Top Buys

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$25M
2
CELG
Celgene Corp
CELG
+$22.9M
3
SRPT icon
Sarepta Therapeutics
SRPT
+$21.2M
4
MGNX icon
MacroGenics
MGNX
+$18.8M
5
MNKD icon
MannKind Corp
MNKD
+$17.8M

Top Sells

Rank Stock Value
1
AEGR
Aegerion Pharmaceuticals
AEGR
+$144M
2
ONXX
ONYX PHARMACEUTICALS INC
ONXX
+$69.5M
3
GILD icon
Gilead Sciences
GILD
+$56.7M
4
RPRX
Repros Therapeutics Inc.
RPRX
+$26.6M
5
QCOR
QUESTCOR PHARMA INC
QCOR
+$21.8M

Sector Composition

Rank Sector Weight
1 Healthcare 85.14%
2 Miscellaneous 12.73%
3 Consumer Staples 2.06%
4 Consumer Discretionary 0.05%
5 Industrials 0.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VNDA icon
126
Vanda Pharmaceuticals
VNDA
$302M
– –
-868,500
Closed -$9.51M
VNDA icon
127
PUT
Vanda Pharmaceuticals
VNDA
$302M
– –
-96,500
Closed -$1.06M
FRTX
128
CALL
DELISTED
Fresh Tracks Therapeutics, Inc. Common Stock
FRTX
– –
-127
Closed -$500K
HNGR
129
DELISTED
Hanger Inc.
HNGR
– –
-4,080
Closed -$138K
ARNA
130
PUT
DELISTED
Arena Pharmaceuticals Inc
ARNA
– –
-255,810
Closed -$13.5M
MGLN
131
DELISTED
Magellan Health Services, Inc.
MGLN
– –
-2,290
Closed -$137K
PGNX
132
DELISTED
Progenics Pharmaceuticals Inc
PGNX
– –
-169,068
Closed -$849K
WCG
133
DELISTED
Wellcare Health Plans, Inc.
WCG
– –
-132,081
Closed -$9.21M
ARRY
134
DELISTED
Array Biopharma Inc
ARRY
– –
-572,870
Closed -$3.56M
MZOR
135
DELISTED
Mazor Robotics Ltd.
MZOR
– –
-177,078
Closed -$2.99M
KERX
136
DELISTED
Keryx Biopharmaceuticals Inc
KERX
– –
-200,000
Closed -$2.02M
AET
137
DELISTED
Aetna Inc
AET
– –
-2,070
Closed -$133K
AMSG
138
DELISTED
Amsurg Corp
AMSG
– –
-3,415
Closed -$136K
KYTH
139
DELISTED
KYTHERA BIOPHARMACEUTICALS, INC COM
KYTH
– –
-2,765
Closed -$126K
NPSP
140
DELISTED
NPS PHARMACEUTICALS INC
NPSP
– –
-305,762
Closed -$9.73M
AVNR
141
PUT
DELISTED
AVANIR PHARMACEUTICALS, INC CL A
AVNR
– –
-193,000
Closed -$816K
ITMN
142
DELISTED
INTERMUNE INC
ITMN
– –
-300,000
Closed -$4.61M
QCOR
143
DELISTED
QUESTCOR PHARMA INC
QCOR
– –
-376,350
Closed -$21.8M
FURX
144
DELISTED
FURIEX PHARMACEUTICALS INC COM STK (DE)
FURX
– –
-5,000
Closed -$220K
ASTX
145
DELISTED
ASTEX PHARMACEUTICALS, INC COM
ASTX
– –
-47,098
Closed -$400K
ONXX
146
DELISTED
ONYX PHARMACEUTICALS INC
ONXX
– –
-556,944
Closed -$69.5M
LPNT
147
DELISTED
LifePoint Health, Inc.
LPNT
– –
-2,995
Closed -$140K
MDVN
148
DELISTED
MEDIVATION, INC.
MDVN
– –
-96,500
Closed -$2.89M
WOOF
149
DELISTED
VCA Inc.
WOOF
– –
-4,715
Closed -$129K
RPRX
150
CALL
DELISTED
Repros Therapeutics Inc.
RPRX
– –
-193,000
Closed -$5.17M
2 3 4 5
6

Similar funds

QP
Quilter Plc London, United Kingdom $6.65B AUM 37.83% 1-Year Est. Return
FCBT
First Citizens Bank & Trust Raleigh, North Carolina $6.69B AUM 24.48% 1-Year Est. Return
RWM
Ritholtz Wealth Management New York $6.7B AUM 32.7% 1-Year Est. Return
AWA
Arkadios Wealth Advisors Atlanta, Georgia $6.6B AUM 30.67% 1-Year Est. Return
WHRC
W.H. Reaves & Co Jersey City, New Jersey $6.59B AUM 31.9% 1-Year Est. Return
KGA
K5 Global Advisor Miami Beach, Florida $6.59B AUM
LSERS
Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return
CAG
Crestwood Advisors Group Boston, Massachusetts $6.74B AUM 30.22% 1-Year Est. Return

Perceptive Advisors's Q4 2013 Portfolio in Review

As of Q4 2013, Perceptive Advisors held 156 positions worth $833M, down 32% from $1.23B the previous quarter. Its ten largest holdings account for 57% of the portfolio.

Perceptive Advisors withdrew a net $240M in Q4 2013, closing 47 positions and reducing 27 holdings. Its most notable exit was ONYX PHARMACEUTICALS INC, an estimated $69.5M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 85% of assets, up from 78% a quarter earlier, followed by Miscellaneous and Consumer Staples.

Against the trend, Perceptive Advisors opened a new position in MacroGenics worth $19.7M.

  • Perceptive Advisors's largest Q4 2013 buy was MacroGenics: 717,705 shares worth $19.7M.
  • Perceptive Advisors added most to Vertex Pharmaceuticals in Q4 2013, an estimated $25M increase.
  • Perceptive Advisors's biggest Q4 2013 reduction was Aegerion Pharmaceuticals, cutting an estimated $144M.
  • Perceptive Advisors fully exited ONYX PHARMACEUTICALS INC in Q4 2013, selling an estimated $69.5M.
  • Perceptive Advisors's ten largest holdings make up 57% of its $833M portfolio in Q4 2013.
  • Perceptive Advisors opened 48 new positions and closed 47 in Q4 2013.
  • Perceptive Advisors's portfolio value fell 32% quarter-over-quarter to $833M.

Based on Perceptive Advisors's 13F filing for Q4 2013, filed 14 Feb 2014.